Government approves 4 medical device parks to cut import bill, production cost

Published On 2019-11-12 04:00 GMT   |   Update On 2019-11-12 04:00 GMT

The four medical device parks will provide the necessary infrastructure, where companies can easily plug and play. This will not only cut import bill but will also help in easy access to standard testing facilities and reduce the cost of production.


New Delhi: The government has given approval for setting up four medical device parks with a view to support Make in India initiative and provide world-class products at an affordable price for treatment.


The four parks will be set up in Andhra Pradesh, Telangana, Tamil Nadu and Kerala, sources said, adding that Uttarakhand and Gujarat have also approached the Centre for a go-ahead for such parks.


These parks will provide necessary infrastructure, where companies can easily plug and play, sources said.


This will not only cut import bill but will also help in easy access to standard testing facilities and reduce the cost of production, they said.


The project of Andhra Pradesh Medtech Zone for creation of Common Facility Centre (CFC) for Superconducting Magnetic Coil Testing and Research was given in-principle approval recently.


The scheme proposes to provide Rs 25 crore or 70 per cent of the project cost of setting up of CFCs, whichever is less, for creation of common facilities in any upcoming park.


Read Also: Even Personal Assistants of Judges draw more salary than Madras Govt Doctors: Madras HC


According to estimates, the medical devices retail market in the country is around Rs 70,000 crore. The domestic medical devices industry is very small even though India is the fourth largest market in Asia.


India is largely an importer of medical devices, with domestic industry accounting for about 2 per cent of the global industry which stands at USD 250 billion, as per the estimates.


Read Also: Total footfall at Govt hospitals OPD increased to 6 crores: Delhi CM

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News